Several studies have indicated the important role of thymic environment, in which T cells differentiate and mature, in imposing the H-2 restriction on T cells (1) . These findings were incorporated by Katz et al. (2) into the framework of his "adaptive differentiation" hypothesis. The H-2 restriction of maturing T cells was investigated primarily in experiments using bone marrow radiation chimeras with or without thymic grafts, both in T cell-mediated cytotoxicity (3, 4) and in T helper celldependent antibody responses (2, [5] [6] [7] [8] [9] [10] [11] . Thymic environment during T cell maturation also affected immune response (Ir) 1 gene function (10, 11) . In studies set up in parallel in the same systems or in other systems, tolerance induced by neonatal tolerization, in contrast to bone marrow chimeras, was not usually found to unveil a T cell repertoire specific for antigen in association with the tolerated allogeneic H-2 antigens (7, 12) , although exceptions were observed (13) .
We have studied the mechanisms of regulation of the immune response to myoglobin (Mb), especially the cellular mechanisms of Ir gene control. We have found two H-2-1inked genes controlling both the T cell proliferative response and the antibody response to Mb, mapping in different I subregions, I-A, and I-C, of the H-2 complex (14) (15) (16) . In a recent study, we found that the Ir gene defect correlated with the inability of (high responder × low responder) F1 T cells to cooperate with low responder B cells, even in the presence of functional Fa antigen-presenting cells (APC) and even when the B cells could be demonstrated to be primed (by their ability to receive help from carrier-specific T cells). 5 In all of these studies using high and low responder B cells and/or APC, the T cells had to be F1 hybrids to avoid allogeneic effects. Therefore, to explore directly the role of helper T cells in the response controlled by Ir genes, alloreactivity had to be eliminated. The method we elected to use was neonatal tolerization, partly to avoid the effects on the T cell repertoire previously observed in radiation chimeras, as noted above. Neonatal mice were injected intravenously with F1 spleen cells and the collaboration of T cells from tolerized mice with B cells from high responder, low responder, or F1 mice was studied.
Not only did we find that low responder mice had T cells competent to help the antibody response to Mb in vitro, but we found that this help was due to a repertoire in the tolerized low-responder mice specific for Mb in association with high responder alloantigens, i.e., a repertoire for antigen plus allo-major histocompatibility complex (MHC), which we did not expect to find in the neonatally tolerant mouse, in which the thymus is homozygous for the low responder H-2 haplotype. These observations are discussed in terms of the following questions: (a) Is the H-2 restriction of helper T cells exclusively determined by the thymic environment in which T cells differentiated and matured or also by the extrathymic environment? (b) Are there normally clones of T cells specific for Mb in the context of the H-2 d high responder haplotype present in low responder mice, but masked by allogeneic effects? (c) What is the role of helper T cells in the genetic control of the response to Mb? Materials and Methods Animals. B10.D2/nSn, B10.BR/SgSn, B10.A(5R)/SgSn, C57BL/10 Sn, (B10.D2 × B10.BR) F1, and B6D2 F1 mice were obtained from The Jackson Laboratory, Bar Harbor, ME. The B10.HTT and (B10.D2 x C57BL/10) F1 mice were bred by us, the former from breeding pairs obtained from Dr. David H. Sachs of the National Institutes of Health (NIH). Mice were 8-16 wk of age at the first immunization.
Antigens. Sperm whale Mb was obtained from Accurate Chemical & Scientific Corp. (Westbury, NY). The major chromatographic component, IV, purified as described previously (14) by the method of Hapner et al. (17) , was used throughout these studies. Fowl gamma globulin (chicken) (FTG) from United States Biochemical Corp. (Cleveland, OH) was used.
Mb Coupling to F'yG. Preparation of Mb-eoupled FyG (Mb-FTG) was performed by a modification of the method described by Schroer et al. (18) . Two bifunetional reagents, methyl-4-mercaptobutyrimidate hydrochloride (MBI) and m-maleimido-benzoyl N-hydroxy-succinimide ester (MBS) (Pierce Chemical Co., Rockford, IL) were used to couple Mb to F'I~G; 2.4 mg of MBS in 0.12 ml of dimethylformamide (Pierce Chemical Co.) were added to 1/zmol of Mb in 0.8 ml of 0.1 M sodium phosphate buffer (NaPi), pH 7.1, and allowed to react for 1 h at 20°C with occasional stirring. The Mb-MBS solution was dialyzed against 0.05 M NaPi, pH 7.1, for 1.5 h. 100 nmol of FyG was dissolved in 0.14 ml of 0.05 M NaPi, pH 7.1, with 0.1 mM Dt-dithiothreitol (DTT) (Sigma Chemical Co., St. Louis, MO); 0.3 mg of MBI in 0.3 ml of 0.05 M NaPi, pH 7.1, with 0.1 mM DTT, was added to the FyG solution. The FyG and MBI solution was allowed to react for 1 h at 20°C with occasional stirring under argon gas to reduce oxidation. The MB!-F7 G solution was dialyzed against 0.05 M NaPi, pH 7.1, with 0.01 mM DTT for 1.5 h under argon gas. After centrifugation of both MBS-Mb and MBI-FyG solutions, the MBI-FyG and MBS-Mb solutions were mixed and allowed to react for 3 h at 20°C under argon gas with occasional stirring. The Mb-F'yG solution was kept in 0.05 M NaPi, pH 7. l, with 0.4 mM DTT, overnight to block residual active sites of maleimide on the MBS-Mb. The Mb-FTG was purified by gel filtration on Sephadex G75 (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piseataway, N J) to remove excess reactants. The sterilized Mb-FTG was stable and stored at 4°C in phosphate-buffered saline (PBS). The preparation of Mb-FyG used throughout these experiments was characterized as follows: the molar substitution of Mb to FyG was 1.5; the concentration of Mb was 0.53 mg/ml and that of FTG was 3.13 mg/ml. The concentrations specified in the cultures are those of the FyG moiety.
Immunization Schedule. Mice were immunized intraperitoneally with 150/zg of purified Mb or with 200 #g of Mb-coupled FyG (Mb-FyG) in PBS emulsified 1:1 in complete Freund's adjuvant (H37Ra; Difco Laboratories, Detroit, MI) in total volume of 0.1 ml/animal. 3 wk after immunization, the mice were boosted intraperitoneally with 0.1 #g of purified Mb or Mb-F,fl3 in PBS, and they were killed 1-2 wk later.
Cell Culture. The culture system, modified from that of Mishell and Dutton (19) , was described in a previous paper (16) . Briefly, 2.5 × 106 spleen cells from immunized mice were cultured with 1 or 0.1 #g/ml of Mb or 0.01 or 0.001 #g/ml of Mb-FyG in 1.5 ml of RPMI 1640 medium (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) supplemented with 10% heat-inactivated fetal calf serum (FCS) (Microbiological Associates, Walkersville, MD), 100 U/ml penicillin, 100 #g/ml streptomycin, 2 mM L-glutamine, and 5 X 10 -5 M 2-mercaptoethanol in flat-bottomed wells (3524; Costar, Data Packaging, Cambridge, MA) for 10 d at 37°C, 6% CO2 on a rocking platform. On the 4th d, 1 ml ofsupernatant was exchanged for fresh medium. On the 10th d, culture supernatants were harvested to measure the secreted antibodies.
Preparation of Spleen Cells. Spleen cells were prepared by gentle teasing of spleens, using forceps, in cold balanced salt solution (BSS, NIH Media Unit). The cell suspensions were treated with ammonium chloride lysing buffer to lyse the erythrocytes, and were washed with RPMI 1640 medium containing 5% FCS.
Preparation of T Cells. T cells were prepared by passage of spleen cells over nylon fiber columns (1 × 108 cells/g of nylon) and collection ofnylon-nonadherent eluate (20) . Nonadherent cell populations were irradiated with 250 rad from a 137Cs source to eliminate memory B cells.
Preparation of B Cells and Accessoo~ Cells. B cells and accessory cells were prepared by depleting
splenic T cells by treatment with a rabbit antibody against mouse brain-associated antigen (RaMB) (Litton Bionetics, Kensington, MD) and guinea pig complement (Gp C') (Cedarlane low tox complement; Accurate Chemical & Scientific Corp.).
Preparation of Splenic Glass-adherent Cells (SAC).
The preparation of SAC was described previously (16) .
Sephadex GIO Passage. Sephadex G10 (Pharmacia Fine Chemicals) passage of spleen cells was performed by a modification of the method described by Hodes et al. (21) . Briefly, 3 × 108 cells in 4 ml BSS containing 8% FCS (BSS-FCS) were added to a 30-ml Sephadex G10 column, incubated at 37°C for 45 min, and eluted with warmed BSS-FCS, collecting the first 20 ml of effluent. These effluent cells were resuspended in BSS-FCS and loaded on the second Sephadex G10 column. After incubation, the first 20 ml of effluent was collected and resuspended in culture medium.
Radioimmunoassayfor Antibody to Mb. The assay of antibody to Mb in the culture supernatant was performed by a solid-phase radioimmunoassay technique as described elsewhere (16 MLR. 4 × 105 spleen cells were cultured with 4 × 105 stimulator cells, which were irradiated with 2,000 rad in 0.2 ml of Click's medium (NIH Media Unit) containing 2 mM glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin (all from Gibco Laboratories), 5 X 10 -5 M 2-mercaptoethanol (Microbiological Associates) and 0.8% fresh normal mouse serum. After 5 d, 0.5 pCi (methyl-3H) thymidine ([nH]TdR, New England Nuclear, Boston, MA; sp act 6.7 Ci/m mole) was added, and after 4 additional h at 37°C, the cells were harvested in an automated collecting device (Microbiological Associates). Proliferation was estimated by scintillation counting of the 3H incorporated into cellular DNA. All cultures were performed in flat-bottomed tissue culture plates (3596; Costar).
Treatment of T Cells with
CML. Cytotoxie T lymphocytes were generated by suspending 4 × 10 s responder cells in 2 ml of minimum essential medium (MEM) (Flow Laboratories, Inc., Rockville, MD) supplemented with FCS for 5 d in a 5% CO2 humidified air atmosphere with 3 × 106 stimulator cells irradiated with 2,000 rad (23) . This number of stimulator cells was found to be more than sufficient to elicit maximal CML reactivit~ in all strain combinations tested. After harvest,sthe cells were assayed for their ability to lyse Cr-labeled 48-h concanavalin A blasts in a 4-h Cr release assay. Responses are expressed as mean percent specific lysis of triplicate determinations; percent specific lysis is calculated as: (epm experimental -cpm medium control)/(cpm maximum release -cpm medium control). The CML was generously performed by Dr. Ronald E. Gress, NIH.
Results

Spleen Cells from Neonatally Tolerized Mice Were Unresponsive to Tolerized H-2 Alloantigens.
To assess the tolerance of neonatally tolerized mice, their ability to respond to the tolerated alloantigens was assessed by means of MLR and CML. An example is shown in Table I Fig. 1, tolerized B10 .D2 or B10.BR T cells or (B10.D2 × B10.BR) F1 B cells were unresponsive to Mb by themselves. However, when T ceils from B10.D2 were cocultured with B cells from F1, B10.D2 T cells helped F1 B cells quite well. Because B10.D2 mice were shown to be high responders to Mb in vivo or in vitro (14) (15) (16) , the ability of B10.D2 T cells to help Fx B cells was reasonably expected. On the other hand, low responder B 10.BR T ceils tolerized to H-2 a alloantigens also could help Fx s In the present paper we do not experimentally distinguish between B cells and APC. However, in a subsequent paper, we show that these effects involve a2genetic restriction in T cell-B cell interaction, whether or not they also involve a T celI-APC restriction. (Fig. 2) . Because the allogeneic effect should have been the same in both cases, these data argue strongly against a positive allogeneic effect as the source of the help. However, one might argue that an allogeneic effect could enhance a weak response due to antigen-primed T cells. Therefore, we intentionally co-cultured FIB cells with untolerized Mb-immune low responder T cells or untolerized nonimmune (normal) low responder T cells in the presence of Mb to test the degree of allogeneic help that could be observed in this combination. F1 B cells cocultured with either normal low responder T cells or Mb immune (nontolerant) low responder T cells produced only a very low antibody response to Mb in the culture supernatants, and the response with immune T cells was no greater than that with nonimmune T cells (data not shown). Therefore, any allogeneic help produced by low responder T cells was very small and was not enhanced by antigen priming. Taken together, these experiments demonstrate that the response to Mb by F1 B cells with the help of tolerized low responder T cells was not due to an allogeneic effect. One additional piece of evidence against an allogeneic effect is presented below. (Figs. 4-6 ). These data indicated B cells in low responder were primed with Mb. Tolerized low responder C57BL/10 T cells help (B10.D2 X C57BL/10) F1 and B10.D2 B cells but not syngeneic low responder C57BL/10 B cells (Fig. 4) . As a control, the B10.D2 and C57BL/10 B cells from mice immunized with Mb-FyG both produced antibodies to Mb in the supernatants when cultured with syngeneic FyG-primed T cells in the presence of Mb-FTG (Fig. 4) (data for B10.D2 cultured with Mb-FyG not shown). The unlikely possibility of allogeneic help due to residual T cells in the B 10.D2 B cell population was excluded by mixing the B10.D2 and B10 B cell populations. No response was seen in these mixtures without added T cells. Similarly, neonatally tolerized low responder B 10.BR T cells helped high responder B 10.D2 B cells but not syngeneic B10.BR B cells, both of which were immunized with Mb-FyG (Fig. 5) .
Tolerized Low Responder B I O.BR or C57BL/ l O T Cells Help Ft B Cells. 3 As shown in
T Cells in the Tolerized
High Responder T Cells Tolerized to Low Responder MHC Fail To Help Low Responder B Cells and APC.
It has been reported (26) that removal of alloreactivity by negative selection with bromodeoxyuridine and (BUdR) light unmasks a responder T cell population that can proliferate in response to antigen presented on low responder APC. We wanted to see whether higher responder B 10.D2 T cells, neonatally tolerized to lower responder B 10.BR (H-2 k) alloantigens, would help B 10.BR B cells and APC. The result (Fig. 6 ) was that such B10.D2 T cells did not help B10.BR B cells, even though the latter were adequately primed as demonstrated by their response to MbFyG. An additional result of this experiment was to lend further support to the conclusion above that the help observed was not due to positive allogeneic effects. In 
Discussion
The data presented here indicated that clones of helper T cells specific for Mb exist in low responder mice and that these low responder T cells can collaborate with high responder B cells when alloreactivity is eliminated. At least two mechanistic questions arise. (a) How do these helper cells arise in the repertoire? (b) How are they primed to be specific for Mb in the context of alloantigen? The former, more difficult, question is addressed below. The latter question, we believe, is more straightforward. Because we can detect 2-4% chimerization by F1 cells in the spleens of the tolerized mice, we believe these may be sufficient during immunization in vivo for clones of T cells restricted to the high responder alloantigens (H-2 a) to be primed. Using a FACS, we consistently observed 2-4% F1 cells in the spleens of neonatally tolerized mice at 10-16 wk of age. In contrast, in most of the mice we could detect no F1 cells in the thymus (see below). 4 Similarly, Streilein et al. (25) have reported detecting variable chimerization, from 0.2 to 4.0% FI cells in the spleen, but none detectable (<0.1%) in the thymus.
It might be argued that the collaboration across H-2 barriers reported here could be due to an allogeneic effect (28) (29) (30) , even though no alloreactivity could be detected by MLR or CML (Table I [ 31] ). We can exclude this possibility as follows: nonimmune low responder tolerized T cells could not help Fa B cells, and immune high responder tolerized T cells could not help low responder B cells. If a positive allogeneic effect were the cause of our results, one or both of these controls should have been positive. Furthermore, under our culture conditions, little or no allogeneic help could be elicited even intentionally.
Another trivial explanation would be that the help is produced not by the low responder T cells themselves, but by high responder F1 T cells chimerizing the tolerized host. Even though chimerization was <5%, this was still a concern. The evidence against it is twofold: (a) the helper T cells from low-responder tolerized mice pretreated with antibodies to alloantigens and complement, to abolish contaminating chimeric F1 cells, could still help F1 B cells; (b) in these culture conditions, a ratio of T cells to B cells of < 1:3 or :4 did not result in antibody production (16) . Furthermore, if varying ratios of Mb-primed F1 T cells were mixed with unprimed F1 T cells and help for syngeneic F1 B cells assessed, 5% primed T cells were insufficient to produce help for a response to Mb. In other words, a contamination with <5% F1 T cells would not have been sufficient to produce the help observed. From these two different sorts of experiments, it is very unlikely that contaminating chimeric F1 T cells provided the help for F1 B cells.
Having ruled out these two artifactual explanations of our results, we conclude that the present results demonstrate that genotypic low responder (H-2 k or 1-1-2 b) T cells neonatally tolerized to higher responder H-2 a antigens can provide Mb-specific help for high responder H-2 a B cells and APC. Two types of explanations are possible for the existence of these helper T cells specific for antigen in the context of allogeneic MHC antigens. (a) Such cells may be present normally in low responder mice but masked by allogeneic effects. When alloreactivity is removed, they are unmasked and can be detected. (b) The process of neonatal tolerization may actually expand the T cell repertoire at the same time that alloreactivity is eliminated.
The first type of explanation, that such cells are normally present but masked by allogeneic effects, can be broken down further into two possibilities. First, it is possible that the repertoire is normally present in all animals for most antigens in the context of most haplotypes. This concept would be consistent with several studies in which alloreactivity was acutely depleted (26, 32, 33) . The second possibility is that the repertoire for reactivity across allogeneic barriers occurs only for certain combinations of antigen and foreign MHC, because these combinations cross-react with another antigen in association with self-MHC (i.e., Mb plus H-2 d is recognized as a crossreaction by T cells really specific for H-2 k plus some other antigen [X] ). This idea is consistent with the observations of Doherty and Bennink (34, 35) . However, it has at least two problems. First, it would require that such an exceptional case apply to both 1t-2 b and 1t-2 k low responders, suggesting that it may not be so exceptional a situation. Second, it requires the implicit assumption that what is recognized is a neoantigenic determinant formed between H-2 d and Mb, which can cross-react with another neoantigenic determinant formed between H-2 k and antigen X or between 1-1-2 b and antigen Y. It is less compatible with mechanisms involving dual recognition of antigen plus MHC, or even less stringent "altered self" hypotheses (1) .
The second type of explanation, namely that the process of neonatal tolerization actually expands the T cell repertoire, can also be divided into two subcategories--intrathymic and extrathymic mechanisms. First, it is possible that neonatal tolerization by injection of adult F1 spleen cells at birth alters the T cell repertoire by altering the thymic environment. This mechanism would be consistent with observations made in bone marrow chimeras (1, 5, 10, 11) , except that the thymic component bearing the foreign MHC antigens could not be the thymic epithelium, as has been suggested, but would have to be circulating cells, such as lymphocytes or macrophages of the donor, which could enter the host thymus, in agreement with the observations of Longo and Schwartz (36) in chimeras. However, Streilein et al. (25) have observed chimerization only in the periphery, not in the thymus, in mice neonatally tolerized by a procedure similar to ours. To test this question in our own mice, we examined tolerized animals by use of the FACS at the time of the culture experiments. Although most mice showed 2-4% peripheral chimerization with F1 cells in the spleen, only rare mice showed detectable F1 cells in the thymus. This result makes this mechanism less likely, but it remains a possibility, as we cannot exclude the presence of F1 cells in the thymus below our limits of detection, or during a short period after tolerization.
Second, if neonatal tolerization leads to an alteration of T cell repertoire without chimerization of the thymus, it is possible that the repertoire is developed extrathymically. This possibility is compatible with the observation of peripheral chimerization without thymic chimerization. Moreover, there is precedent for such a suggestion in the studies of cytotoxic T cells in thymus-engrafted nude mice by Zinkernagel et al. (37) , Lake et al. (38) , and Kruisbeek et al. (39) . It is more difficult, however, to reconcile extrathymic repertoire development with the contraction of the repertoire in F1 ~ parent bone marrow chimeras despite peripheral F1 cells (1-6, 9, 10, 40, 41) , or with the restriction to the thymic parental haplotype of helper cells from ~ nude mice engrafted with a parental thymus (42) and homozygous nude mice engrafted with an allogeneic thymus (43) .
Thus, whether intrathymically or extrathymically, the act of neonatal tolerization could have altered the T cell repertoire of such tolerant mice to include clones of T cells capable of cooperating with high responder B cells and APC. The current study cannot distinguish these mechanisms from each other or from the possibility that the repertoire of T cells capable of cooperating with high responder B cells and APC may normally be present in the low responder mouse, but just masked by alloreactivity.
Although our results agree with those of Forman et al. (13) in the cytotoxic T cell response of neonatally tolerized mice, they appear to be somewhat discrepant with the results for neonatally tolerized mice in a virus-specific cytotoxic response (12, 40) , and with those for the antibody response of cells acutely depleted of alloreactivity by filtration through an irradiated F1 host (44, 45) . The 1-1-2 K/D-restricted cytotoxic responses may not be directly comparable to the Ia-restricted antibody responses as these repertoires may be affected differently by neonatal tolerization (25, 46) (as well as in bone marrow chimeras [43] ). In the case of the antibody response to sheep erythrocytes studied by Sprent and von Boehmer (44), the differences may be caused by differences in the method of tolerization. On the one hand, the acute depletion method may also remove some of the repertoire for exogenous antigen seen in the context of the tolerated Ia. On the other hand, long-term tolerance from birth may allow the emergence of a repertoire not unmasked by the short-term depletion of alloreactive cells immediately before experimental culture. Finally, neonatal tolerization may possibly alter the repertoire, as discussed above.
Besides the chimera studies and acute depletion studies mentioned above, there are a few other studies in the literature that suggest that low responder T cells can be elicited for a response to the antigen under lr gene control if they are immunized or induced by the proper route. For instance, Pierce and Kapp (47) showed that helper T cells specific for L-glutamic acid6°-L-alaninen°-L-tyrosinel° (GAT) on low responder APC could be elicited by immunizing F1 mice with antigen bound to those APC. Araneo et al. (48) found helper T cells for a lysozyme response in the popliteal lymph nodes of low responder mice early but not late in the course of the response. However, both the GAT and lysozyme responses involve active suppression in the low responder. Nevertheless, even for cases in which no suppression has been demonstrable as a mechanism of Ir gene control, such as responses to (
, and IgG myeloma protein (51) , the elicitation of helper T cells in low responders has been possible by various manipulations.
Finally, our observation that high responder T cells tolerant to low responder MHC antigens cannot help low responder B cells and APC appears to be in disagreement with the observation of Ishii et al. (26) that acute depletion of alloreactivity with BUdR and light allows responder T cells to proliferate in response to antigen presented on low responder APC. One difference may be that the secondary antibody response we are studying involves a T cell-B cell restriction as well as a possible T cell-APC restriction, in contrast to the proliferative response which involves only the latter. 2 However, a second difference between our results lies in the methods of removal of alloreactivity. Treatment of alloreactive cells undergoing an MLR with BUdR results in uptake of the BUdR into the DNA of the dividing cells. Subsequent exposure to ultraviolet light produces cross-linking of the DNA and thus prevents further replication. Although these cells cannot proliferate again in a secondary MLR, they are not necessarily killed, and may still carry out functions not requiring replication, such as positive allogeneic effects which may enhance weak antigen-specific proliferative responses caused by residual high responder APC. Moreover, the T cell proliferative response may be more susceptible to such positive allogeneic effects than the secondary in vitro antibody response, which in our hands is rather insensitive to such effects.
It should also be pointed out that these results agree with some of the findings of Pierce et al. (52) but not others. These investigators studied allogeneic mixes of T cells and B cells in an Ir gene-controlled antibody response in a splenic fragment culture system. In our system, as in theirs, low responder T cells could collaborate with high responder B cells but not with low responder B cells. The only discrepancy between the two studies is that we do not find that high responder T cells, tolerant to low responder MHC, help low responder B cells. One difference was that their low responder B cells were specific for a hapten, not for the antigen under Ir gene control as in the present study. However, the difference also may be caused by the fact that in the splenic fragment system, no specific attempt was made to remove alloreactivity. Thus, the response observed could have been influenced by positive allogeneic effects, although controls were done to suggest otherwise. On the other hand, the hypothesis of Pierce et al. (52) predicts that specific tolerization of the high responder to low responder alloantigens would eliminate the repertoire they described for antigen in the context of low responder alloantigens. Thus, it can never be tested, by definition, in the absence of possible allogeneic effects (and for the same reason, is not actually incompatible with our results).
How do these results help us to pinpoint the Ir gene defect for the antibody response to Mb? Because low responder B cells can be primed to Mb by using Mb-FyG and produce anti-Mb in the presence of FyG-specific help, we know that the low responder has competent Mb-specific B cells. In this study, we also found competent Mb-specific helper T cells in the low responder, which were not phenotypically different from those in the high responder, in that both helped only high responder or Fa B cells and APC, not low responder B cells and APC. Thus, the defect may be in neither the T cell nor the B cell alone, but in the interaction between low responder T cells and low responder B cells and APC, or may reflect selective priming of helper cells by APC during in vivo immunization, which is then mirrored by a T cell-B cell restriction in vitro. In a subsequent paper, we will demonstrate that at least one defect exists in T cell-B cell collaboration, independent of the source of APC. 2
Summary
We sought to examine the role of immune response (Ir) genes in helper T cells. To eliminate allogeneic effects, we used neonatally tolerized mice. The results bear not only on the mechanism of lr genes, but also on the development of the T cell repertoire. B 10.BR (H-2 k) or C57BL/10 (H-2 b) ix.ice, which were low responders to myoglobin (Mb), were neonatally tolerized to high responder H-2 a alloantigens, and B10.D2 mice, which were high responders to Mb, were neonatally tolerized to low responder H-2 k or H-2 b alloantigens. Spleen cells from these tolerized mice did not show any reactivity in mixed-lymphocyte reaction or cell-mediated lympholysis against alloantigens used in tolerization. Mb-immune F1 B cells were helped comparably by Mb-immune tolerized low or high responder T cells. Thus, low responder T cells functioned equivalently to high responder T cells. The failure of nonimmune T cells from tolerized low responder mice to help F1 B cells and antigen-presenting cells (APC) indicated that collaboration between B10.BR or C57BL/10 T cells and F1 B cells was not caused by a positive allogeneic effect. Spleen cells from tolerized mice were contaminated with 2-4% chimeric F1 cells, as judged by fluorescence-activated cell sorter analysis, and no Fa alloantigens were detectable in the thymus. However, removal of chimeric F~ T cells from the tolerized cell population by treatment with anti-H-2 and complement did not change the helper activity of tolerized low responder T cells. These data indicated that helper activity in the T cell population from low responder mice was not due to F~ cells. Also, the level of contamination was not sufficient to quantitatively account for the help. In examining the genetic restriction of these tolerized T cells, we found that T cells from tolerized low responder B 10.BR or C57BL/10 mice helped F1 or high responder B10.D2 B cells and APC but not syngeneic B10.BR or C57BL/10 B cells and APC, which were immunized with Mbcoupled fowl gamma globulin instead of Mb to prime low responder B cells with Mb. On the other hand, high responder B 10.D2 tolerized T cells helped syngeneic B 10.D2 B cells but not allogeneic low responder B10.BR B cells.
These data indicated that clones of helper T cells specific for Mb exist in low responder mice, and these are not phenotypically different from those in high responder mice, in that both help high responder and Ft but not low responder B cells and APC. These data are discussed in terms of the mechanism for Ir gene control, and the mechanism of T cell repertoire development--whether intra-or extrathymically--in neonatally tolerized mice.
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